Associated Papers
The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.
Song KH et al.
Molecular Therapy. Oncology, 2024
39354956 (PubMed )
Supplement: mmc2.pdf
Select a paper to view details